As in DS–ALL, there is a high incidence of genetic alterations affecting signaling effectors (NRAS, KRAS, FLT3, and SH2B3) in HeH and iAMP21 subtypes [129–131]. The gene discussed is FLT3; the disease is acute lymphoblastic leukemia.